[PDF][PDF] Resposta objetiva tumoral e taxas de sobrevida de pacientes com cirrose e carcinoma hepatocelular submetidos à radioembolização com ¹³¹I-lipiodol versus …
MCO Ribeiro - 2023 - repositorio.unesp.br
Introdução: O carcinoma hepatocelular (CHC) ocorre principalmente em portadores de
cirrose e seu tratamento envolve terapias como a quimioembolização transarterial (TACE) …
cirrose e seu tratamento envolve terapias como a quimioembolização transarterial (TACE) …
How Much Time Should Be Waited and What Are the Main Findings to Evaluate the Hepatocellular Carcinoma Response to Regorafenib? A Real‐Life Experience
GH Kawanami, L Katsuda, TB Rocha… - Canadian Journal of …, 2021 - Wiley Online Library
Background. Hepatocellular carcinoma is a relevant cause of mortality worldwide, mainly
among patients who have a prior liver disease. In spite of clear recommendations regarding …
among patients who have a prior liver disease. In spite of clear recommendations regarding …
[PDF][PDF] Research Article How Much Time Should Be Waited and What Are the Main Findings to Evaluate the Hepatocellular Carcinoma Response to Regorafenib? A …
GH Kawanami, L Katsuda, TB Rocha… - 2021 - academia.edu
Background. Hepatocellular carcinoma is a relevant cause of mortality worldwide, mainly
among patients who have a prior liver disease. In spite of clear recommendations regarding …
among patients who have a prior liver disease. In spite of clear recommendations regarding …
[HTML][HTML] Combining loco-regional treatments in early hepatocellular carcinoma: new achievements overcoming old limitations
NA de Moura, FG Romeiro - Translational Cancer Research, 2017 - tcr.amegroups.org
Comment on: Vasnani R, Ginsburg M, Ahmed O, et al. Radiofrequency and microwave
ablation in combination with transarterial chemoembolization induce equivalent …
ablation in combination with transarterial chemoembolization induce equivalent …
Combined strategies for hepatocellular carcinoma treatment: a new hope
FG Romeiro, M do Val Ietsugu - AME Medical Journal, 2017 - amj.amegroups.org
Hepatocellular carcinoma (HCC) is the most common tumor of the liver and the third cause
of cancer death worldwide (1). Noteworthy, HCC incidence has increased in the last …
of cancer death worldwide (1). Noteworthy, HCC incidence has increased in the last …